Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
16.9M
-
Shares change
-
+1.6M
-
Total reported value, excl. options
-
$16.9M
-
Value change
-
+$1.62M
-
Put/Call ratio
-
0.85
-
Number of buys
-
24
-
Number of sells
-
-17
-
Price
-
$1.00
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2025
57 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q1 2025.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.9M shares
of 65.9M outstanding shares and own 25.71% of the company stock.
Largest 10 shareholders include AVENIR CORP (5.04M shares), Skylands Capital, LLC (3M shares), VANGUARD GROUP INC (1.95M shares), NEUBERGER BERMAN GROUP LLC (1.68M shares), CM Management, LLC (954K shares), Sargent Investment Group, LLC (824K shares), BlackRock, Inc. (627K shares), GEODE CAPITAL MANAGEMENT, LLC (614K shares), Granahan Investment Management, LLC (358K shares), and RENAISSANCE TECHNOLOGIES LLC (225K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.